Big Gain For Pacific Biosciences of California, Inc.
Wed, Sep 30, 2026 at 07:35 PM
Pacific Biosciences of California, Inc. (PACB:NASDAQ) soared at $2.37, representing a gain of 29.5%. On Wed, Sep 30, 2026, PACB:NASDAQ touched a New 2-Week High of $2.37. The stock got featured on our News Catalysts scanner on Sat, Sep 26, 2026 at 12:04 AM in the 'INVESTOR UPDATE' category. From Wed, Sep 16, 2026, the stock recorded 70.00% Up Days and 63.64% Green Days
About Pacific Biosciences of California, Inc. (PACB:NASDAQ)
Pacific Biosciences of California Inc is a biotechnology company. It is engaged in design, development and manufacture of sequencing system to help scientists resolve genetically complex problems.
Top 10 Gainers:
- NewGenIvf Group Limited (NIVF:NASDAQ), 133.33%
- GOWell Energy Technology (GOW:NASDAQ), 75.7%
- Tenon Medical, Inc. (TNON:NASDAQ), 49.82%
- Pacific Biosciences of California, Inc. (PACB:NASDAQ), 29.51%
- Masonglory Limited (MSGY:NASDAQ), 27.48%
- Armada Acquisition Corp. II (XRPN:NASDAQ), 27.13%
- Republic Power Group Ltd (RPGL:NASDAQ), 26.31%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 26.15%
- Lion Group Holding Ltd. (LGHL:NASDAQ), 25.94%
- Zhibao Technology Inc. (ZBAO:NASDAQ), 25.31%